Table 3. The distribution of duration of symptoms (in months) and stage by phenotypes, Uganda delay study, 2013.

Duration of symptoms	Over all	Early stage n=34	Late stage n=139	Luminal A n=68	Luminal B n=12	HER2+ n=33	TNBC n=45	Missing n=25	P value
Mean duration	29	21	23	26	17	19	21	23	-
Median duration	12	12	12	21	24	12	12	24
SD	26	21	28	30	10	18	33	16
Percentiles
25	7	6	7	8	6	7	6	9	-
50	12	12	12	21	24	12	12	24
75	24	24	30	34	24	27	24	36
Missing	-	6	10	7	-	2	5	-
Duration categories									0.370
<3 months				6	0	2	6
3-6 months				7	1	5	7
6-12 months				12	3	12	12
12-24 months				24	6	6	12
>24 months				19	1	9	9
Total				68	11	34	46
Duration by stage at diagnosis
I				8	1	1	2	<0.001
II				18	3	4	2
III				41	6	26	37
IV				6	2	5	6
Total				73	12	36	47